Luan Xue
Overview
Explore the profile of Luan Xue including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
73
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li R, Ding Y, Xue L
BMC Rheumatol
. 2025 Feb;
9(1):21.
PMID: 39985118
Background: Gout is a chronic disease caused by the deposition of sodium urate crystals, which is prone to multiple comorbidities, especially cardiovascular and kidney diseases. Patients with gout have higher...
2.
Yu S, Yang Z, Ding Z, Jia Y, Wan L, Li L, et al.
J Nucl Med
. 2025 Feb;
66(3):418-424.
PMID: 39947914
The objective of this study was to evaluate the feasibility of using Ga-labeled fibroblast activation protein inhibitor-04 (Ga-FAPI-04) PET/CT imaging as a molecular tracer and noninvasive tool for assessing active...
3.
Pan D, Dai X, Li P, Xue L
Int J Chron Obstruct Pulmon Dis
. 2025 Feb;
20:259-271.
PMID: 39944597
Background: Previous studies have found an association between ankylosing spondylitis (AS) and chronic obstructive pulmonary disease (COPD); however, no research has investigated this relationship using Mendelian randomization (MR). Methods: This...
4.
Jia Q, Wang Y, Sun D, Mao J, Xue L, Gu X, et al.
Chin J Integr Med
. 2024 Dec;
31(2):99-107.
PMID: 39707138
Objective: To explore the efficacy and safety of Juan Bi Pill (JBP) in treatment of active rheumatoid arthritis (RA). Methods: From February 2017 to May 2018, 115 participants from 4...
5.
Piao X, Wu X, Yan Y, Li Y, Li N, Xue L, et al.
Int Immunopharmacol
. 2024 Oct;
143(Pt 1):113201.
PMID: 39353382
Objective: The enhancer of zeste 2 polycomb repressive complex 2 subunit (EZH2) can regulate osteogenesis and osteoclastogenesis. This study aimed to further explore the effects of EZH2 modification on ferroptosis...
6.
Yang Y, Chen Y, Li Y, Feng Y, Hu N, Xue L
Biomed Res Int
. 2024 Jul;
2022:6255383.
PMID: 39050559
Atherosclerosis (AS) is a chronic inflammatory disease that occurs in artery walls, which seriously affects the survival and prognosis of patients with systemic lupus erythematosus (SLE). Immune and inflammatory responses...
7.
Hou J, Feng Y, Yang Z, Ding Y, Cheng D, Shi Z, et al.
Eur J Med Res
. 2024 Jul;
29(1):371.
PMID: 39014509
Primary Sjögren's syndrome (pSS) is a chronic autoimmune disease primarily affecting exocrine glands such as the salivary glands, leading to impaired secretion and sicca symptoms. As the mainstay of salivation,...
8.
Ding Y, Chen J, Li R, Xue L
Front Immunol
. 2024 Mar;
15:1289049.
PMID: 38482005
Background: Inflammatory bowel disease (IBD) and ankylosing spondylitis (AS) share common traits of chronic recurrent inflammation affecting both the intestines and joints. Epidemiological studies have revealed that the incidence of...
9.
10.
Ding Y, Yang Y, Xue L
Front Immunol
. 2023 Apr;
14:1137523.
PMID: 37063924
Background: The close relationship between ankylosing spondylitis (AS) and inflammatory bowel diseases (IBD) has been supported by many aspects, including but not limited to clinical manifestations, epidemiology and pathogenesis. Some...